2'-Deoxycytidine-13C9

• UNSPSC Description:

  2'-Deoxycytidine-13C9 (Deoxycytidine-13C9; Cytosine deoxyriboside-13C9; Deoxyribose cytidine-13C9) is 13C-labeled 2'-Deoxycytidine (HY-D0184). 2'-Deoxycytidine, a deoxyribonucleoside, could inhibit biological effects of Bromodeoxyuridine (Brdu).

• Target Antigen:

  Endogenous Metabolite; Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Metabolic Enzyme/Protease;Others

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/2-deoxycytidine-13c9.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=[13C]1N([13C@H]2[13CH]([H])[13C@H](O)[13C@@H]([13CH2]O)O2)[13CH]=[13CH][13C](N)=N1

• Molecular Weight:

  236.15

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Horn D, et al. Inhibition of biological effects of bromodeoxyuridine by deoxycytidine: correlation with decreased incorporation of bromodeoxyuridine into DNA. Somatic Cell Genet. 1976 Sep;2(5):469-81.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported